Seeds Investor’s Quest Diagnostics DGX Stock Holding History

Seeds Investor’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,886	Closed	-$260K	–	175
2023 Q4	$260K	Buy	+1,886	New	+$248K	0.29%	103

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Seeds Investor's DGX Position: Q1 2024 in Review

Seeds Investor sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 1,886 shares — an estimated $260K sold.

Seeds Investor first reported a position in DGX in Q4 2023 and held it in 1 quarter. The position peaked at $260K in Q4 2023. 818 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

Seeds Investor reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
Seeds Investor sold 1,886 Quest Diagnostics shares in Q1 2024, an estimated $260K.
Seeds Investor first reported a position in Quest Diagnostics in Q4 2023 and held it in 1 quarter.
Seeds Investor's Quest Diagnostics position peaked at $260K in Q4 2023.
818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Seeds Investor's 13F filing for Q1 2024, filed 10 May 2024.